Search

BCN HEALTH has published the study “Economic consequences of premature mortality due to brain cancer in Spain: a human capital approach” in Current Medical Research and Opinion, a peer-reviewed

ProtoQSAR has launched ProtoAD, a new tool integrated into the ProtoPRED platform, developed in response to the needs identified among its users.

MedTech Barcelona is expanding its portfolio with new solutions that meet industry needs and strengthen its position in biomedical and pharmaceutical research.

Spanish study describes that hypocaloric Mediterranean diet combined with physical activity reduces the risk of diabetes.

Basque Health Cluster and Mondragon Unibertsitatea launch a new edition of the Expert Course in Medical Device and IVD Regulation.

Organized in collaboration with CIC bioGUNE and CIC biomaGUNE, the event will gather leading experts to address advances in glycobiology, immunology, and carbohydrate chemistry. Registration for the

The European project ShapingBio, of which AseBio is a partner, has presented a report with key recommendations for the upcoming EU Bioeconomy Strategy, aimed at driving a more sustainable, circular

Jordi Gibert Amat, Head of the Biotechnology Business Unit at Klinea Biotech & Pharma Engineering, Platinum Sponsor of BIOSPAIN 2025, analyzes the contribution of biotechnology to the pharmaceutical

Meet Danae UroGenomics, our new member. We spoke with Marta Dueñas, Founder.

Various studies estimate that genetic factors explain between 20–30% of the variability in lifespan.

Líder mundial en genómica, Illumina ofrece soluciones integrales de secuenciación de nueva generación en los ámbitos clínicos, de investigación y de aplicaciones.

The engineering solutions development company for the pharmaceutical and biotechnology sector is clear that the future of the industry must be built on a strong commitment to sustainability values.

Immunobiogram® is a test that measures in vitro the sensitivity (response) of each patient's immune system cells to immunosuppressive drugs, with the aim of facilitating the personalization of

First iadademstat clinical trial in non-malignant hematological indications.

The project, which launched on June 1, 2025, aims to develop an innovative platform for the non-invasive detection of minimal residual disease (MRD) in lung cancer patients using multi-omic biomarkers

The biotechnology company Mikrobiomik has begun patient recruitment for LiverGut, the first clinical trial in Europe to evaluate an oral therapy based on gut microbiota aimed at slowing the

Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant, and €1

Inveready completes its third venture capital fund with a 4.3x return on capital invested by shareholders

Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial

The European Health Data Space (EHDS) is conceived as a federated, interoperable, secure and privacy-focused infrastructure, integrating health data generated in all Member States.

A study led by Dr. Iñaki Comino-Méndez and Dr. Emilio Alba from the Hospital Universitario Virgen de la Victoria of Málaga/IBIMA and Dr. Ángel Guerrero-Zotano from the Instituto Valencia de Oncología